Free Trial

Vir Biotechnology (VIR) SEC Filings & 10K Form

Vir Biotechnology logo
$4.50 -0.11 (-2.39%)
Closing price 05/23/2025 04:00 PM Eastern
Extended Trading
$4.42 -0.08 (-1.67%)
As of 05/23/2025 07:41 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Vir Biotechnology SEC Filings

DateFilerForm TypeView
05/09/2025
7:23 AM
Vir Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/28/2025
12:02 PM
BlackRock, Inc. (Filed by)
Vir Biotechnology (Subject)
Form SCHEDULE 13G/A
04/17/2025
8:27 AM
Vir Biotechnology (Filer)
Form ARS
04/17/2025
7:40 AM
Vir Biotechnology (Filer)
Form DEFA14A
04/17/2025
7:33 AM
Vir Biotechnology (Filer)
Form DEF 14A
04/04/2025
3:23 PM
De Backer Marianne (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2025
6:50 PM
De Backer Marianne (Reporting)
Vir Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/27/2025
11:39 AM
de Verneuil Vanina (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
5:01 AM
Vir Biotechnology (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/26/2025
3:23 PM
de Verneuil Vanina (Reporting)
Vir Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/25/2025
2:43 PM
HANLY ANN M. (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2025
2:44 PM
SCANGOS GEORGE A (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2025
2:34 PM
de Verneuil Vanina (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2025
2:36 PM
De Backer Marianne (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2025
2:37 PM
Sabatini Brent (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2025
2:39 PM
Eisner Mark (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2025
2:41 PM
O'Byrne Jason (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/24/2025
7:56 PM
HANLY ANN M. (Reporting)
Vir Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/24/2025
7:57 PM
Sabatini Brent (Reporting)
Vir Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/24/2025
7:57 PM
SCANGOS GEORGE A (Reporting)
Vir Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/24/2025
7:38 PM
De Backer Marianne (Reporting)
Vir Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/24/2025
7:40 PM
de Verneuil Vanina (Reporting)
Vir Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/19/2025
6:11 PM
SCANGOS GEORGE A (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
6:50 PM
SCANGOS GEORGE A (Reporting)
Vir Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/14/2025
5:41 PM
Sabatini Brent (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2025
5:49 PM
Sabatini Brent (Reporting)
Vir Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/30/2025
6:51 AM
Vir Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2025
7:03 PM
SATO VICKI L (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
3:22 PM
SATO VICKI L (Reporting)
Vir Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2025
6:50 AM
Vir Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/18/2024
12:36 PM
O'Byrne Jason (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/07/2024
6:20 PM
de Verneuil Vanina (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2024
4:51 PM
de Verneuil Vanina (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/31/2024
3:20 PM
Vir Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/24/2024
3:26 PM
SCANGOS GEORGE A (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/18/2024
11:29 AM
STATE STREET CORP (Filed by)
Vir Biotechnology (Subject)
Form SC 13G/A
10/02/2024
11:09 AM
Sabatini Brent (Reporting)
Vir Biotechnology (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/02/2024
11:07 AM
de Verneuil Vanina (Reporting)
Vir Biotechnology (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/10/2024
3:28 PM
Napolitano Janet (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2024
7:10 AM
Vir Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/09/2024
3:29 PM
Napolitano Janet (Reporting)
Vir Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
Musk’s AI Masterplan – Our #1 AI Stock to Buy Now (Ad)

Missed Nvidia? This Under-the-Radar AI Stock Could Be Next Musk's AI empire is just beginning — and one overlooked company could be at the center of it all. We reveal everything in this exclusive Memorial Day webinar.

Reserve your spot before it's gone >>>
08/01/2024
3:43 PM
Vir Biotechnology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/16/2024
3:40 PM
Eisner Mark (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/10/2024
2:26 PM
SHARP PHILLIP A (Reporting)
Vir Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/26/2024
7:15 AM
Vir Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/12/2024
11:21 AM
Ramasastry Saira (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
4:01 PM
PEREZ ROBERT J (Reporting)
Vir Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/05/2024
5:04 AM
Vir Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/03/2024
11:15 AM
Ramasastry Saira (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
11:16 AM
SATO VICKI L (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
11:17 AM
SCANGOS GEORGE A (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
11:18 AM
Sigal Charles Elliott (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
10:57 AM
Eisner Mark (Reporting)
Vir Biotechnology (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/03/2024
10:59 AM
Hatfield Jeffrey S. (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
11:08 AM
MORE ROBERT J (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
11:13 AM
Napolitano Janet (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
11:14 AM
NELSEN ROBERT (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2024
1:38 PM
BISCHOFBERGER NORBERT W (Reporting)
Vir Biotechnology (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/31/2024
1:40 PM
BISCHOFBERGER NORBERT W (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2024
1:42 PM
Farid Ramy (Reporting)
Vir Biotechnology (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/31/2024
1:43 PM
Farid Ramy (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
3:06 PM
Vir Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:VIR) was last updated on 5/24/2025 by MarketBeat.com Staff
From Our Partners